Clinical Trial Update: A Research Study to Evaluate the Safety and Tolerability of SGC001 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and tolerability of SGC001 in healthy subjects; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• SGC001

Snippet

Sponsor: Beijing Sungen Biomedical Technology Co., Ltd | Conditions: Anterior Myocardial Infarction | Phase 1 | Status: COMPLETED